Get the Stockscreener App
0.93
4.21%
0.0376
After Hours:
.96
0.03
+3.23%
Chimerix Inc stock is traded at $0.93, with a volume of 95,340.
It is up +4.21% in the last 24 hours and down -0.23% over the past month.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
See More
Previous Close:
$0.8924
Open:
$0.8756
24h Volume:
95,340
Relative Volume:
0.21
Market Cap:
$82.47M
Revenue:
$324.00K
Net Income/Loss:
$-82.10M
P/E Ratio:
0.4515
EPS:
2.06
Net Cash Flow:
$-69.18M
1W Performance:
+8.96%
1M Performance:
-0.23%
6M Performance:
-12.26%
1Y Performance:
-3.10%
1-Day Range:
$0.871
$0.9435
1-Week Range:
$0.812
$0.9435
52-Week Range:
$0.75
$1.30
Chimerix Inc Stock (CMRX) Company Profile
Name
Chimerix Inc
Sector
Industry
Phone
919.806.1074
Address
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
Chimerix Inc Stock (CMRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Apr-29-21 | Initiated | Maxim Group | Buy |
| Apr-23-21 | Resumed | Cowen | Outperform |
| Mar-31-21 | Initiated | Jefferies | Buy |
| Mar-31-21 | Initiated | Wedbush | Outperform |
| Feb-14-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-02-18 | Initiated | H.C. Wainwright | Buy |
| Aug-09-16 | Reiterated | FBR Capital | Mkt Perform |
| Feb-23-16 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-23-16 | Reiterated | FBR Capital | Mkt Perform |
| Feb-23-16 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-22-16 | Downgrade | Citigroup | Buy → Neutral |
| Dec-29-15 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-28-15 | Downgrade | FBR Capital | Outperform → Mkt Perform |
| Dec-28-15 | Reiterated | Piper Jaffray | Overweight |
| Dec-17-15 | Initiated | UBS | Buy |
| Oct-05-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-03-15 | Initiated | Citigroup | Buy |
| Aug-18-15 | Initiated | FBR Capital | Outperform |
| Aug-06-15 | Reiterated | Brean Capital | Buy |
| May-11-15 | Reiterated | Brean Capital | Buy |
| Mar-04-15 | Initiated | Barclays | Overweight |
| Feb-12-15 | Reiterated | Stifel | Buy |
| Dec-31-14 | Reiterated | Brean Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
View All
Chimerix Inc Stock (CMRX) Latest News
Copart, Inc. (NASDAQ:CPRT) Shares Sold by Xponance Inc. - Defense World
Investor’s Delight: Compass Inc (COMP) Closes Strong at 6.20, Up 0.16 - The Dwinnex
Copart, Inc. (NASDAQ:CPRT) Shares Acquired by Summit Trail Advisors LLC - Defense World
Pacer Advisors Inc. Has $6.38 Million Stock Position in Copart, Inc. (NASDAQ:CPRT) - Defense World
Intech Investment Management LLC Sells 115,103 Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - MarketBeat
Providence Capital Advisors LLC Acquires Shares of 61,800 Microchip Technology Incorporated (NASDAQ:MCHP) - MarketBeat
C.H. Robinson Worldwide (NASDAQ:CHRW) Sets New 12-Month High at $105.70 - Defense World
What is COMP’s price-to-sales ratio telling us about the company’s value? - US Post News
Company’s Banking Stock: Dissecting a -38.92% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Investors in cash trouble should check out Cross Country Healthcares, Inc. (CCRN) - SETE News
C.H. Robinson Worldwide Sees Unusually High Options Volume (NASDAQ:CHRW) - MarketBeat
CHRS stock touches 52-week low at $1.01 amid market challenges - Investing.com India
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Analytical Overview: Coherus Biosciences Inc (CHRS)’s Ratios Tell a Financial Story - The Dwinnex
Davidson Kempner Capital Management LP Acquires Shares of 150,000 C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - Defense World
Integral Health Asset Management LLC Buys Shares of 275,000 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
A stock that deserves closer examination: Coherus Biosciences Inc (CHRS) - US Post News
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Epoch Investment Partners Inc. Buys 29,098 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation - Yahoo Finance
Barrow Hanley Mewhinney & Strauss LLC Buys 299,721 Shares of Microchip Technology Incorporated (NASDAQ:MCHP) - Defense World
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St
Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat
Barrow Hanley Mewhinney & Strauss LLC Grows Stake in Microchip Technology Incorporated (NASDAQ:MCHP) - MarketBeat
Mercury Systems, Inc. (MRCY): Street Analysts Are Bearish On This Aviation Stock - Yahoo Finance
Mutual of America Capital Management LLC Cuts Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) Shares Purchased by Acadian Asset Management LLC - Defense World
C.H. Robinson Worldwide, Inc. [CHRW] stock for 283,855 USD was sold by Campbell Ben G - Knox Daily
Inspire Investing LLC Lowers Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
Bridges Investment Management Inc. Buys 539,300 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Chimerix (NASDAQ:CMRX) Stock Price Crosses Below Two Hundred Day Moving Average of $0.95 - MarketBeat
Railway stock hits 5% upper circuit after receiving order worth ₹ 127.4 Cr for steel sheet piles - Trade Brains
Choreo LLC Purchases New Stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - Defense World
Sienna Gestion Trims Stake in Copart, Inc. (NASDAQ:CPRT) - Defense World
Copart, Inc. (NASDAQ:CPRT) Shares Purchased by Burgundy Asset Management Ltd. - Defense World
Catalyst Pharmaceuticals stock hits 52-week high at $20.88 - Investing.com
E Fund Management Co. Ltd. Increases Stock Position in Copart, Inc. (NASDAQ:CPRT) - Defense World
Waterloo Capital L.P. Purchases 1,517 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Resolute Capital Asset Partners LLC Acquires 10,000 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
Quest Partners LLC Purchases Shares of 934 Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
Compass Inc [COMP] Is Currently 2.03 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Is Coherus Biosciences Inc (CHRS) positioned for future growth? - SETE News
Federated Hermes Inc. Sells 134 Shares of Cimpress plc (NASDAQ:CMPR) - Defense World
CHRS stock rated a Neutral by UBS - Knox Daily
Trading Day Review: Compass Minerals International Inc (CMP) Gains Momentum, Closing at 11.15 - The Dwinnex
A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA - Yahoo Finance
C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) Holdings Lowered by State of New Jersey Common Pension Fund D - Defense World
C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) Shares Sold by DekaBank Deutsche Girozentrale - Defense World
Compass Minerals: A Risky But Interesting Prospect (NYSE:CMP) - Seeking Alpha
Resolute Holdings Completes Acquisition of Majority Interest in CompoSecure - ForexTV.com
Chimerix Inc Stock (CMRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):